...
alt-img

Altimmune Inc, Common Stock

ALT

NMQ

$9.11

-$0.03

(-0.33%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$700.58M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.28M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.07
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.71 L
$14.84 H
$9.11

About Altimmune Inc, Common Stock

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameALTSectorS&P500
1-Week Return6.3%-2.12%0.77%
1-Month Return24.62%-2.54%2.65%
3-Month Return46.94%-6.28%12.3%
6-Month Return35.36%-1.36%13.48%
1-Year Return32.41%9.29%33.47%
3-Year Return-1.73%10.05%32.22%
5-Year Return384.57%43.69%92.85%
10-Year Return-98.22%103.1%194.31%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue5.80M8.19M4.41M(68.00K)426.00K[{"date":"2019-12-31","value":70.88,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":53.88,"profit":true},{"date":"2022-12-31","value":-0.83,"profit":false},{"date":"2023-12-31","value":5.2,"profit":true}]
Cost of Revenue17.07M33.51M551.30K68.00K477.00K[{"date":"2019-12-31","value":50.93,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":1.65,"profit":true},{"date":"2022-12-31","value":0.2,"profit":true},{"date":"2023-12-31","value":1.42,"profit":true}]
Gross Profit(11.26M)(25.32M)3.86M(136.00K)(51.00K)[{"date":"2019-12-31","value":-291.89,"profit":false},{"date":"2020-12-31","value":-656.23,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.52,"profit":false},{"date":"2023-12-31","value":-1.32,"profit":false}]
Gross Margin(194.16%)(309.40%)87.50%200.00%(11.97%)[{"date":"2019-12-31","value":-97.08,"profit":false},{"date":"2020-12-31","value":-154.7,"profit":false},{"date":"2021-12-31","value":43.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.99,"profit":false}]
Operating Expenses26.27M62.98M89.95M87.67M96.36M[{"date":"2019-12-31","value":27.26,"profit":true},{"date":"2020-12-31","value":65.37,"profit":true},{"date":"2021-12-31","value":93.36,"profit":true},{"date":"2022-12-31","value":90.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(21.46M)(54.80M)(96.91M)(87.74M)(95.93M)[{"date":"2019-12-31","value":-2146493500,"profit":false},{"date":"2020-12-31","value":-5479874100,"profit":false},{"date":"2021-12-31","value":-9691404100,"profit":false},{"date":"2022-12-31","value":-8774000000,"profit":false},{"date":"2023-12-31","value":-9592900000,"profit":false}]
Total Non-Operating Income/Expense1.73M650.33K20.26K5.69M14.80M[{"date":"2019-12-31","value":11.67,"profit":true},{"date":"2020-12-31","value":4.39,"profit":true},{"date":"2021-12-31","value":0.14,"profit":true},{"date":"2022-12-31","value":38.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(20.58M)(54.46M)(97.09M)(84.91M)(88.45M)[{"date":"2019-12-31","value":-2057863100,"profit":false},{"date":"2020-12-31","value":-5446150100,"profit":false},{"date":"2021-12-31","value":-9709082400,"profit":false},{"date":"2022-12-31","value":-8491000000,"profit":false},{"date":"2023-12-31","value":-8844700000,"profit":false}]
Income Taxes(58.50K)(5.42M)(919.51K)(197.00K)309.11K[{"date":"2019-12-31","value":-18.93,"profit":false},{"date":"2020-12-31","value":-1752.49,"profit":false},{"date":"2021-12-31","value":-297.48,"profit":false},{"date":"2022-12-31","value":-63.73,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(20.52M)(49.04M)(96.17M)(84.71M)(88.76M)[{"date":"2019-12-31","value":-2052013100,"profit":false},{"date":"2020-12-31","value":-4904447700,"profit":false},{"date":"2021-12-31","value":-9617131100,"profit":false},{"date":"2022-12-31","value":-8471300000,"profit":false},{"date":"2023-12-31","value":-8875610500,"profit":false}]
Income From Continuous Operations(20.52M)(49.04M)(97.09M)(84.71M)(88.45M)[{"date":"2019-12-31","value":-2052013100,"profit":false},{"date":"2020-12-31","value":-4904447700,"profit":false},{"date":"2021-12-31","value":-9709082400,"profit":false},{"date":"2022-12-31","value":-8471300000,"profit":false},{"date":"2023-12-31","value":-8844700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(20.52M)(49.04M)(96.17M)(84.71M)(88.45M)[{"date":"2019-12-31","value":-2052013100,"profit":false},{"date":"2020-12-31","value":-4904447700,"profit":false},{"date":"2021-12-31","value":-9617131100,"profit":false},{"date":"2022-12-31","value":-8471300000,"profit":false},{"date":"2023-12-31","value":-8844700000,"profit":false}]
EPS (Diluted)(1.51)(1.91)(2.36)(1.77)(1.44)[{"date":"2019-12-31","value":-151,"profit":false},{"date":"2020-12-31","value":-191,"profit":false},{"date":"2021-12-31","value":-236,"profit":false},{"date":"2022-12-31","value":-177,"profit":false},{"date":"2023-12-31","value":-144,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ALT
Cash Ratio 16.14
Current Ratio 16.87

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ALT
ROA (LTM) -39.56%
ROE (LTM) -72.96%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ALT
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ALT
Trailing PE NM
Forward PE NM
P/S (TTM) 13472.64
P/B 4.69
Price/FCF NM
EV/R 9376.51
EV/Ebitda NM
PEG NM

FAQs

What is Altimmune Inc share price today?

Altimmune Inc (ALT) share price today is $9.11

Can Indians buy Altimmune Inc shares?

Yes, Indians can buy shares of Altimmune Inc (ALT) on Vested. To buy Altimmune Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ALT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Altimmune Inc be purchased?

Yes, you can purchase fractional shares of Altimmune Inc (ALT) via the Vested app. You can start investing in Altimmune Inc (ALT) with a minimum investment of $1.

How to invest in Altimmune Inc shares from India?

You can invest in shares of Altimmune Inc (ALT) via Vested in three simple steps:

  • Click on Sign Up or Invest in ALT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Altimmune Inc shares
What is Altimmune Inc 52-week high and low stock price?

The 52-week high price of Altimmune Inc (ALT) is $14.84. The 52-week low price of Altimmune Inc (ALT) is $4.71.

What is Altimmune Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Altimmune Inc (ALT) is

What is Altimmune Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Altimmune Inc (ALT) is 4.69

What is Altimmune Inc dividend yield?

The dividend yield of Altimmune Inc (ALT) is 0.00%

What is the Market Cap of Altimmune Inc?

The market capitalization of Altimmune Inc (ALT) is $700.58M

What is Altimmune Inc’s stock symbol?

The stock symbol (or ticker) of Altimmune Inc is ALT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top